Among the many fascinating points discussed in this session are a number of key issues including (time of discussions within the video are listed in parenthesis):
1:03 -- A review of types of procedures in peripheral intervention that require antiplatelet therapy;
3:50 -- What does the antiplatelet therapy consist of in peripheral interventional cases?
8:00 -- Are we rational in how we are approaching the choice in terms of mono-therapy in PAD patients?
12:10 -- What is the evidence in PAD intervention in terms of the impact of clopidegrel response on the risk on negative outcomes?
15:00 -- Is there a relationship between size of the artery and thrombotic risk?
18:30 -- In terms of drug response, are there clear lessons from peripheral arterial intervention that can be taken from cardiology?
21:45 -- How common are major bleeding complications in peripheral arterial interventions?
24:05 -- Are we going to see more studies in different organ areas as we have seen in cardiology?
The panel for this session comprises:
Robert Storey, University of Sheffield, UK (Chair);
Stavros Spiliopoulos, Patras University Hospital, Rion, Greece;
Jeff Dahlen, Chief Scientific Officer at Accumetrics, US.
Radcliffe Cardiology and Interventional Cardiology Review extends its thanks to all panel members.
In the third session from the Platelet Reactivity Testing Round Table Discussion, the panel discuss procedures in peripheral intervention that require antiplatelet therapy.